Company: BIAF
Filing Date: 2025-06-27
Form Type: POS AM
Source: 0001641172-25-016923
Chunk: 132

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-27
Form: POS AM
Chunk 132
---
 Zannes, there are no other family relationships among any of the Company’s director nominees or executive officers.

Director Independence

Under the corporate governance standards of Nasdaq, a majority of our directors must meet the independence requirements specified in those rules. The Nasdaq listing standards also subject members of the Company’s Audit Committee and Compensation Committee to additional independence requirements. The Board has affirmatively determined that each of the Company’s current non-employee directors, which include Robert Anderson, Stuart Diamond, Peter Knight, Gary Rubin, and Jamie Platt are independent directors under the Nasdaq rules and listing standards, including with respect to each director’s committee service.

| 77 |

<div align='center'>EXECUTIVE AND DIRECTOR COMPENSATION</div>

We are an “emerging growth company” and a “smaller reporting company” under applicable federal securities laws and therefore permitted to take advantage of certain reduced public company reporting requirements. As such, we provide in this prospectus the scaled disclosure permitted under the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, including the compensation disclosures required of a “smaller reporting company,” as that term is defined in Rule 12b-2 promulgated under the Exchange Act.

The Company’s executive officers named in the Summary Compensation Table below are referred to herein as the “named executive officers” or “NEOs”. These named executive officers are:

| ● 
 ● | Maria                                                                                                              
 Zannes, J.D. - President, Chief Executive Officer, and Director                                                    
 J.                                                                                                                 
 Michael Edwards - Chief Financial Officer (beginning November 5, 2024); Interim Chief Financial Officer (September 
 16, 2024 through October 31, 2024)                                                                                 |
|:--|:-------------------------------------------------------------------------------------------------------------------|
| ● | Steven                                                                                                             
 Girgenti - Executive Chairman and Director                                                                         |

Summary Compensation Table

The table below summarizes all compensation awarded to, earned by, or paid to our named executive officers for all services rendered in all capacities to us and our subsidiaries during the fiscal years noted below:

| Name                        
 and  Principal Position     |     | Year |     | Salary ($) |         |     | Bonus ($) |        |     | Stock Awards ($) (1) |         |     | Option Awards ($) |   |     | Non-Equity Incentive Plan Compensation ($)(2) |        |     | All Other Compensation ($)(3) |        |     | Total ($) |         |
| Maria Zannes